NDC 71209-077 – Olanzapine
Olanzapine 15 mg/1 · Tablet · Oral
Product NDC71209-077
Product details
- Brand name
- Olanzapine
- Generic name
- Olanzapine
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA210022
- Marketed since
- February 13, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Olanzapine 15 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 71209-077-01 | 30 TABLET in 1 BOTTLE (71209-077-01) | Feb 13, 2019 |
| 71209-077-05 | 100 TABLET in 1 BOTTLE (71209-077-05) | Oct 4, 2023 |
| 71209-077-10 | 500 TABLET in 1 BOTTLE (71209-077-10) | Oct 4, 2023 |
| 71209-077-11 | 1000 TABLET in 1 BOTTLE (71209-077-11) | Feb 13, 2019 |
Other Olanzapine products
- 67877-172 Olanzapine 2.5 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-175 Olanzapine 10 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-174 Olanzapine 7.5 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-176 Olanzapine 15 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-177 Olanzapine 20 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-173 Olanzapine 5 mg/1 · Tablet · Ascend Laboratories, LLC
- 65862-561 Olanzapine 2.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-566 Olanzapine 20 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-564 Olanzapine 10 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-565 Olanzapine 15 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-563 Olanzapine 7.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-562 Olanzapine 5 mg/1 · Tablet · Aurobindo Pharma Limited